The Starpharma Holdings share price slumped 10.5% on Wednesday

The Starpharma Holdings Limited (ASX: SPL) share price fell 10.55% on Wednesday, closing the session at $1.06.

This came despite the Melbourne-based pharmaceutical company announcing that its condom that kills certain STIs will soon be sold in Japan, one of the world’s largest condom markets.

Starpharma’s VivaGel condom contains a lubricant gel proven in laboratory settings to kill HIV, the herpes virus and HPV, the human papillomavirus that causes cervical cancer.

Starpharma said on Wednesday the condom had received final regulatory approval in Japan and will be sold there by leading Japanese condom manufacturer Okamoto Industries under a licensing agreement.

Okamoto executive Keiji Ikeda said that condoms with functional gels represent the next wave in innovation in Japan, following a previous focus on condom thinness.

Starpharma CEO, Dr. Jackie Fairley, called the regulatory approval “a key commercial milestone” for the condom.

VivaGel condoms are also approved for sale in Australia and Canada, where they are sold as LifeStyles Dual Protect Condoms.

The Starpharma share price has fallen 22.63% over the last 12 months, compared to the S&P/ASX 200 Index, which has fallen roughly 8.3%.

with AAP

The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!